Arbutus, Burford Capital, And Cadiz With Chris DeMuth Jr.
Chris DeMuth, Jr. shares some of his current top picks. Arbutus Biopharma is a promising investment due to its potential litigation value from IP claims against Pfizer and Moderna related to COVID-19 vaccine technology.
Recent Price Trend in Cadiz (CDZI) is Your Friend, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Cadiz (CDZI) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Cadiz (CDZI) Reports Q3 Loss, Misses Revenue Estimates
Cadiz (CDZI) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.12 per share a year ago.
Will Cadiz (CDZI) Report Negative Q3 Earnings? What You Should Know
Cadiz (CDZI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Under-$10 Stocks With the Potential to Make You a Millionaire
Buying low-priced stocks with explosive potential is any investor's dream — but it's not easy. Many stocks trade under $10 in the market, yet not all are quality picks.
Cadiz to Participate in the iAccess Alpha Buyside Best Ideas Summer Conference 2024
LOS ANGELES, CA / ACCESSWIRE / June 13, 2024 / Cadiz, Inc. (NASDAQ:CDZI)(NASDAQ:CDZIP) ("Cadiz" or the "Company"), a California water solutions company, announced today that management will participate in the iAccess Alpha Buyside Best Ideas Summer Conference 2024 being held virtually on June 25 and 26, 2024. Cadiz Chairman and CEO Susan Kennedy will deliver a virtual presentation on June 25, 2024, at 10:30 am ET focused on how Cadiz is bringing innovative solutions and financing structures to the water sector.
